To view the fulltext, please log in
To view the pdf, please log in
Objective and Importance: Complications arising from the placement of ventriculoperitoneal (VP) shunts are well documented. A case of infertility is presented that was thought to result from factors related to the distal end of a VP shunt residing within a patient’s abdomen. Clinical Presentation: A 30-year-old female with a 3-year history of infertility was referred for fallopian tube blockage. An exploratory laparoscopy revealed multiple adhesions adjoining the distal end of her fallopian tubes. The distal portion of a VP shunt placed at childhood (with subsequent revisions) was found entangled among grossly inflamed and densely adhesive pelvic viscera. Intervention: Laparoscopic adhesiolysis was performed and the patient’s fallopian tubes were reconstituted. The distal portion of the VP shunt was freed from the surrounding viscera and was not revised. Conclusion: VP shunts may produce adhesive disease and complicate fertility via mechanical, chemical, and/or infectious processes.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- Bryant MS, Bremer AM, Tepas JJ 3rd, Mollitt DL, Nquyen TQ, Talbert JL: Abdominal complications of ventriculoperitoneal shunts. Case reports and review of the literature. Am Surg 1988;54:50–55.
- Agha FP, Amendola MA, Shirazi KK, Amendola BE, Chandler WF: Abdominal complications of ventriculoperitoneal shunts with emphasis on the role of imaging methods. Surg Gynecol Obstet 1983;156:473–478.
- Redman JF, Seibert JJ: Abdominal and genitourinary complications following ventriculoperitoneal shunts. J Urol 1978;119:295–297.
- Roitberg BZ, Tomita T, McLone DG: Abdominal cerebrospinal fluid pseudocyst: a complication of ventriculoperitoneal shunt in children. Pediatr Neurosurg 1998;29:267–273.
- Yount RA, Glazier MC, Mealey J Jr., Kalsbeck JE: Cerebrospinal fluid ascites complicating ventriculoperitoneal shunting. Report of four cases. J Neurosurg 1984;61:180–183.
- Jimenez DF, Keating R, Goodrich JT: Silicone allergy in ventriculoperitoneal shunts. Childs Nerv Syst 1994;10:59–63.
- Pittman T, Williams D, Rathore M, Knutsen AP, Mueller KR: The role of ethylene oxide allergy in sterile shunt malfunctions. Br J Neurosurg 1994;8:41–45.